chartexchange

Guided Therapeutics Provides Update on its Cervical Cancer Screening Study with Türkiye’s Ministry of Health

Business Wire | Nov 4, 2026 9:00 AM EST

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced that its landmark cervical cancer screening study, conducted with Türkiye’s Ministry of Health (TMOH), has enrolled over 250 of the expected 800 women needed to complete the study. The study, funded by TMOH, is intended to support Türkiye’s plan to use LuViva to screen up to 20 million Türkish women annually. Said Mark Faupel, GTHP’s CEO, “While we are stil

Read original article